
Established in 2011 in Hong Kong, Max Choice has emerged as a prominent player in the market for traditional medical foods. Focusing on products like bird's nests, cordyceps, and Peru Maca, the company has garnered a reputation as a market leader. Throughout its existence, Max Choice has remained committed to introducing effective and convenient natural health products. To fulfill this vision, the company has fostered strong collaborations with partners worldwide, notably Sinoveda in Canada and Honsoukaku (Established in 2011 in Hong Kong, Max Choice has emerged as a prominent player in the market for traditional medical foods. Focusing on products like bird's nests, cordyceps, and Peru Maca, the company has garnered a reputation as a market leader. Throughout its existence, Max Choice has remained committed to introducing effective and convenient natural health products. To fulfill this vision, the company has fostered strong collaborations with partners worldwide, notably Sinoveda in Canada and Honsoukaku (本草閣) in Japan.
Mr. Ng Hung Sum, also known as Sam, is the visionary behind Max Choice, and his extensive experience spans several decades in the industry. Recognizing the untapped potential of herbal supplements, Sam realized that the sector had not fully embraced technological advancements beyond raw forms of these foods.
Driven by his profound passion for traditional Chinese medicine, Sam made strategic investments in Dr. Tam Yun Kau's ventures, which aimed to modernize herbal medicine starting in 2008. Dr. Tam, serving as Sinoveda's Chief Scientific Officer and a former professor of pharmacokinetics at the University of Alberta, has dedicated nearly two decades to successfully developed 14 highly potent botanical supplements, while perfecting the groundbreaking Artificial Intelligence Pharmaceutical Platform Technology (AI-PPT). This technology enables the discernment of intricate plant ingredient combinations, their effects, and the prescription of correct dosages.
Supplements and medicines developed using this cutting-edge technology guarantee the presence of desired active ingredients in the appropriate proportions, ensuring rapid action. In doing so, they surpass the limitations of traditional Chinese medicine whilemaintaining its 100% natural allure and bypassing Western medicine’s side effects.
The fusion of Dr. Tam's research and Max Choice's business acumen shrank the time frame to launch effective herbal solutions, embodying a model balancing swift action with efficacy, benefiting researchers, investors, and consumers. Together, Max Choice and Dr. Tam's squad reshaped the herbal product commercialization journey. Their collaborative efforts encompass a range of natural health solutions, including Cordyceps, Lingzhi, Proflexa and their latest breakthrough, Antico, the globe’s inaugural all-natural remedy for long COVID, boasting a commendable efficacy rate of over 95% in symptom alleviation within just three days.
On the other hand, the collaboration between Max Choice and Honsoukaku (本草閣) in Japan is aimed at enhancing the accessibility of health supplements. Traditional Chinese medicine ingredients such as Maca, Panax Notoginseng, Dendrobium, and Ejiao offer distinctive health benefits when consumed regularly. However, the time-consuming preparation process makes it impractical for most individuals to consume these ingredients on a daily basis. To address this issue, Max Choice has partnered with Honsoukaku, a 180-year-old traditional Chinese medicine clinic and pharmacy in Japan, to transform these ingredients into ready-to-eat sachets that are easy to absorb. By packaging them individually and ensuring they are hassle-free, Max Choice provides the market with 100% natural and additive-free supplements that offer the benefits of traditional Chinese medicine without the inconvenience.?